Cargando…

Hydroxychloroquine: Lack of efficacy following an off-label use: case report

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2021
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8178046/ http://dx.doi.org/10.1007/s40278-021-96900-2

Ejemplares similares

Hydroxychloroquine/lopinavir/ritonavir: Lack of efficacy following off-label use: case report
Publicado: (2022)

Hydroxychloroquine/lopinavir/ritonavir/tocilizumab: Lack of efficacy following off label use: case report
Publicado: (2022)

Azithromycin/favipiravir/hydroxychloroquine: Lack of efficacy and off-label use: case report
Publicado: (2021)

Hydroxychloroquine: Lack of efficacy during off label use treatment: case report
Publicado: (2021)

Ceftriaxone/hydroxychloroquine/lopinavir: Lack of efficacy in off-label use: case report
Publicado: (2021)

Ceftriaxone/cobicistat/darunavir/hydroxychloroquine: Off-label use and lack of efficacy: case report
Publicado: (2022)

Hydroxychloroquine/lopinavir/ritonavir: Lack of efficacy and off label use: 3 case reports
Publicado: (2022)

Azithromycin/eculizumab/hydroxychloroquine: Normocytic anaemia, lack of efficacy and off-label use: case report
Publicado: (2022)

Hydroxychloroquine: Haemolysis following off-label use: case report
Publicado: (2021)

Hydroxychloroquine: Eosinophilia following off-label use: case report
Publicado: (2021)

Hydroxychloroquine: Rash following off label use: case report
Publicado: (2020)

Epoprostenol/hydroxychloroquine/tocilizumab: Acute large bowel perforation, off-label use and lack of efficacy: case report
Publicado: (2020)

Eculizumab: Lack of efficacy following off-label use: case report
Publicado: (2021)

Methylprednisolone: Lack of efficacy following off-label use: case report
Publicado: (2022)

Tocilizumab: Lack of efficacy following off-label use: case report
Publicado: (2022)

Dexamethasone: Lack of efficacy following off-label use: case report
Publicado: (2022)

Hydroxychloroquine: Cardiac toxicity following off-label use: case report
Publicado: (2021)

Hydroxychloroquine: QTc prolongation following off-label-use: case report
Publicado: (2020)

Hydroxychloroquine: QTc-prolongation following an off-label use: case report
Publicado: (2020)

Hydroxychloroquine: QTc prolongation following off-label use: case report
Publicado: (2020)

Hydroxychloroquine: Hypoglycaemia following off-label use: 3 case reports
Publicado: (2020)

Azithromycin/hydroxychloroquine: Methemoglobinemia following off-label use: case report
Publicado: (2020)

Hydroxychloroquine: Liver damage following off-label use: case report
Publicado: (2022)

Multiple drugs: Lack off efficacy following off-label use: 2 case reports
Publicado: (2022)

Hydroxychloroquine: Hepatotoxicity following off-label treatment: case report
Publicado: (2020)

Moxifloxacin/umifenovir: Lack of efficacy following off-label use: case report
Publicado: (2021)

Multiple drugs: Off-label use followed by lack of efficacy: case report
Publicado: (2021)

Multiple drugs: Lack of efficacy following off-label use: case report
Publicado: (2021)

Various drugs: Lack of efficacy following an off-label use: case report
Publicado: (2021)

Cefuroxime/oseltamivir: Lack of efficacy following off label use: case report
Publicado: (2021)

Multiple drugs: Lack of efficacy following off-label use: case report
Publicado: (2022)

Multiple drugs: Lack of efficacy following an off label use: case report
Publicado: (2022)

Multiple drugs: Lack of efficacy following off label use: case report
Publicado: (2022)

Multiple drugs: Lack of efficacy following off-label use: case report
Publicado: (2022)

Azithromycin/enoxaparin sodium/hydroxychloroquine: Gastrointestinal bleeding, ischaemic stroke due to off-label use, and lack of efficacy: case report
Publicado: (2021)

Antibacterials/convalescent-anti-SARS-CoV-2-plasma/hydroxychloroquine: Off-label use and lack of efficacy: case report
Publicado: (2022)

Acetylcysteine/hydroxychloroquine: Haemolysis and inflammation following off-label use of hydroxychloroquine and acetylcysteine: 7 case reports
Publicado: (2020)

Favipiravir: Lack of efficacy following off-label treatment: case report
Publicado: (2021)

Hydroxychloroquine: Elevated aminotransferase levels following off-label use: case report
Publicado: (2021)

Hydroxychloroquine: Torsades de pointes following off label use: case report
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_st09fpjj3r8ruhql0uf3v7vjri